Follicular lymphoma: 2023 update on diagnosis and management
Sign Up to like & getrecommendations! Published in 2022 at "American Journal of Hematology"
DOI: 10.1002/ajh.26737
Abstract: Follicular lymphoma (FL) is generally an indolent B cell lymphoproliferative disorder of transformed follicular center B cells. FL is characterized by diffuse lymphadenopathy, bone marrow involvement, and splenomegaly. Extranodal involvement is less common. Cytopenias are… read more here.
Keywords: lymphoma; diagnosis management; update diagnosis; follicular lymphoma ... See more keywords
Response‐adapted treatment with rituximab, bendamustine, mitoxantrone, and dexamethasone followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma after first‐line immunochemotherapy: Results of the RBMDGELTAMO08 phase II trial
Sign Up to like & getrecommendations! Published in 2019 at "Cancer Medicine"
DOI: 10.1002/cam4.2555
Abstract: Consensus is lacking regarding the optimal salvage therapy for patients with follicular lymphoma who relapse after or are refractory to immunochemotherapy. read more here.
Keywords: adapted treatment; response adapted; treatment rituximab; rituximab bendamustine ... See more keywords
The outcome of watchful waiting in patients with previously treated follicular lymphoma
Sign Up to like & getrecommendations! Published in 2022 at "Cancer Medicine"
DOI: 10.1002/cam4.4588
Abstract: Watchful waiting (WW) is one of the standard approaches for newly diagnosed follicular lymphoma (FL) patients with low‐tumor burden. However, the impact of WW in FL patients at the first progression, remains unclear. We reviewed… read more here.
Keywords: follicular lymphoma; treatment; watchful waiting; first progression ... See more keywords
Subcutaneous rituximab in patients with diffuse large B cell lymphoma and follicular lymphoma: Final results of the non‐interventional study MabSCale
Sign Up to like & getrecommendations! Published in 2022 at "Cancer Medicine"
DOI: 10.1002/cam4.5160
Abstract: Rituximab has become a standard treatment for non‐Hodgkin lymphoma. Clinical studies have demonstrated the efficacy of rituximab in combination with standard chemotherapies in the treatment of follicular lymphoma (FL) and diffuse large B cell lymphoma… read more here.
Keywords: lymphoma; cell lymphoma; follicular lymphoma; large cell ... See more keywords
Accuracy and prognostic impact of FDG PET/CT and biopsy in bone marrow assessment of follicular lymphoma at diagnosis: A Nation‐Wide cohort study
Sign Up to like & getrecommendations! Published in 2022 at "Cancer Medicine"
DOI: 10.1002/cam4.5424
Abstract: In the workup of follicular lymphoma (FL), bone marrow biopsy (BMB) assessment is a key component of FLIPI and FLIPI2, the most widely used outcome scores. During the previous decade, several studies explored the role… read more here.
Keywords: follicular lymphoma; fdg pet; bone marrow;
Small volume biopsy diagnostic yield at initial diagnosis versus recurrence/transformation of follicular lymphoma: A retrospective Cyto‐Heme Interinstitutional Collaborative study
Sign Up to like & getrecommendations! Published in 2022 at "Cancer Cytopathology"
DOI: 10.1002/cncy.22676
Abstract: Few studies have evaluated diagnostic yield of small volume biopsies (SVB) for the diagnosis and management of follicular lymphoma (FL). read more here.
Keywords: diagnostic yield; diagnosis; follicular lymphoma; small volume ... See more keywords
Refractoriness to immunochemotherapy in follicular lymphoma: Predictive factors and outcome
Sign Up to like & getrecommendations! Published in 2017 at "Hematological Oncology"
DOI: 10.1002/hon.2378
Abstract: Follicular lymphoma is characterized by a good response to immunochemotherapy (ICT). However, a small percentage of patients responds poorly to treatment and seems to have a worse outcome. This study attempted to identify the predictive… read more here.
Keywords: lymphoma; predictive factors; immunochemotherapy; follicular lymphoma ... See more keywords
EVALUATION OF CLINICOGENETIC RISK MODELS FOR OUTCOME OF FOLLICULAR LYMPHOMA PATIENTS IN THE PRIMA TRIAL
Sign Up to like & getrecommendations! Published in 2017 at "Hematological Oncology"
DOI: 10.1002/hon.2437_85
Abstract: s from OT01 to OT06 can be found in the pertinent section, after the PUBLICATION section. “FOCUS ON...” SESSION: LYMPHOMA IN THE ELDERLY 87 HIGHER MUTATIONAL BURDEN BUT DOES NOT IMPACT TREATMENT EFFICACY IN FOLLICULAR… read more here.
Keywords: age; treatment; follicular lymphoma; biology ... See more keywords
THE VALUE OF PROGNOSTIC NUTRITIONAL INDEX AT DIAGNOSIS IN PATIENTS WITH FOLLICULAR LYMPHOMA: A RETROSPECTIVE COHORT STUDY
Sign Up to like & getrecommendations! Published in 2017 at "Hematological Oncology"
DOI: 10.1002/hon.2439_130
Abstract: Introduction: The clinical course and prognosis of follicular lymphoma (FL) is diverse. Studies about prognostic nutritional index (PNI), a marker of host inflammatory and nutritional status, indicated that it is associated with prognosis in a… read more here.
Keywords: diagnosis; follicular lymphoma; value; pni ... See more keywords
Management of newly diagnosed high‐risk and intermediate‐risk follicular lymphoma with 90Y ibritumomab tiuxetan in a phase II study
Sign Up to like & getrecommendations! Published in 2018 at "Hematological Oncology"
DOI: 10.1002/hon.2513
Abstract: Five‐year overall survival for high‐risk Follicular Lymphoma International Prognostic Index follicular lymphoma is only approximately 50% compared with 90% for low risk. To evaluate an approach to improve upon this poor outcome, we completed an… read more here.
Keywords: risk; immunotherapy; risk follicular; high risk ... See more keywords
Spontaneous remission of follicular lymphoma
Sign Up to like & getrecommendations! Published in 2019 at "Hematological Oncology"
DOI: 10.1002/hon.2653
Abstract: Follicular lymphoma is an indolent B cells proliferative disorder that represents approximately 35% of all non‐Hodgkin lymphomas. Although spontaneous remission is uncommon in patients with low grade non‐Hodgkin lymphomas, some cases have been reported. We… read more here.
Keywords: spontaneous remission; oncology; follicular lymphoma; remission follicular ... See more keywords